Over the past 3 decades, our ability to noninvasively image structures of the musculoskeletal system has facilitated clinical diagnoses and provided insight into the success of various therapeutic interventions. As imaging modalities are refined and novel approaches are introduced, imaging technologies can provide objective measures to better understand the natural history and mechanisms of diseases and optimize and evaluate their treatment. While traditional radiography and computed tomography are commonly used to evaluate the integrity of bony structures, recent advances include biplanar videoradiography, which can now be used to directly track 3-dimensional joint motion in vivo with a high degree of accuracy. 11 As such, biplanar videoradiography has been applied to study the progression of arthrosis after anterior cruciate ligament (ACL) injury. 4 Based on recent technological advances, ultrasound is now being used to measure cartilage thickness to study the progression of arthrosis in vivo after ACL injury. 8 Likewise, there has been a real boon in the use of magnetic resonance imaging (MRI) to evaluate anatomic, biomechanical, and compositional interactions among the structures of an injured joint. For example, MRI has been used to evaluate compositional changes of the articular cartilage in the injured joint in relation to changes in loading during gait. 13 These kinds of studies provide opportunities to better understand mechanisms of posttraumatic osteoarthritis following joint injury. Furthermore, MRI has been recently applied to gain insight into the mechanisms of ACL injury. 9 By using the projections of the bone bruises that occurred during ligament rupture onto the articular surfaces within the 2 compartments of the knee via models derived from 3-dimensional MRI scans, the position of the tibia relative to the femur at the time of injury can be determined. 9 MRI has also been used to evaluate the structural and mechanical integrity of the menisci 3 and ACL grafts after surgery.
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In this issue, 2 articles utilize novel imaging approaches to assess the integrity of tissues within the joint. The first uses magnetic resonance to directly measure the strain in articular cartilage in response to joint loading, and the second brings together 2 imaging modalities to indirectly assess the integrity of the healing ACL graft and to relate them to clinical outcomes. These 2 studies highlight the potential value of MRI as a research tool to assess the integrity of joint tissues, shed light on the limitations of imaging modalities, and set the stage for future work to better understand the response of the joint to injury and treatment.
In this issue, Sutter et al 12 utilized MRI to measure the thickness of the articular cartilage of the tibiofemoral joint before and after the performance of a repetitive dynamic activity (hopping) among patients with deficient ACLs. By coregistering the cartilage models generated from the images, which were obtained before and after the activity, the residual strains at discrete locations on the cartilage surfaces immediately after the activity was determined. The authors found that the cartilage of the medial femoral condyle adjacent to the femoral notch exhibited a decrease in thickness and an increase in strain (an indicator of cartilage softening) as compared with the uninjured contralateral knee and that the magnitudes of these changes were dependent on the time from injury. This magnetic resonance-based biomechanical analysis demonstrates the discrete regional impact of abnormal loading on cartilage health after injury among patients who are coping with ACL injury, which would have been missed in evaluating larger regions of interest as previously done. Future studies can now be performed to track these changes longitudinally among patients with ACL injury and ACL reconstruction, which in turn could provide insight into if and when it may be reasonable to intervene with surgery.
MRI has been widely used to measure the geometry and vascularity of ligaments and tendons, and efforts are underway to use MRI to predict the biomechanical performance of these structures. 2 In this issue, Garika et al 7 utilized 2 imaging techniques-PET/CT (positron emission tomography/computed tomography) and dynamic contrast-enhanced MRI-to assess ''ligamentization'' of ACL grafts at 4 and 8 months after surgery in a cohort of patients who underwent ACL reconstruction. PET/CT, which requires a radiotracer, was selected to evaluate glucose metabolism in the graft. Dynamic contrast-enhanced MRI was chosen to quantify graft vascularity. The 2 methods focus on 2 features that are important to graft healing and likely predict the long-term integrity of the graft. The methods were found to be independent of each other. Graft revascularization appeared to be related to early patient outcomes. A higher reduction in metabolism at the final follow-up was related to better patient outcome. While establishing relationships between objective measures and patient-reported outcomes is a great first step, it does not provide direct evidence to show that the graft is biomechanically superior. Now that the feasibility of these 2 methods has been established, future work with an animal model to show improved histology and biomechanical properties would be of interest. Nonetheless, these preliminary findings highlight the value of noninvasive imaging to study the healing processes of ligaments and tendons that could provide insight into the optimization of new treatment strategies in the future.
Given the variety of imaging modalities available, and surely many more in development, it leaves the clinical investigator in a quandary regarding which imaging outcome measure to select for a particular study. Another similar challenge is that the sequences and hardware are continually changing. A great example is the use of MRI to evaluate the integrity of articular cartilage. In the early 2000s, quantitative MRI was recommended to measure cartilage volume and/or regional cartilage thickness to quantify the loss of cartilage over time. 6 However, other magnetic resonance approaches emerged because thickness and volume changes were thought to lag behind compositional changes. The dGEMRIC method was then introduced to map the distribution of proteoglycans within the cartilage tissues of the joint, as it is well known that proteoglycan loss is associated with osteoarthritis progression.
14 As dGEMRIC requires the use of contrast agents, researchers next moved to T 2 relaxometry, which was thought to reflect collagen organization. 10 Subsequently, sodium imaging, T 1 rho, and gagCEST have also been introduced. 5 To truly validate any of these methods, long-term follow-up studies are required to show that the variable of interest is predictive of those patients who will present with radiographic osteoarthritis-the gold standard-and, more important, those who will become symptomatic. The selection of the best method for a particular study should be based on the research question being asked and the data available to support the validity of that method. For example, the cartilage imaging approach used by Sutter et al 12 is an extension of the quantitative MRI method to measure cartilage thickness but at very discrete locations across the articular cartilage surfaces. A robust coregistration method across images was required. The authors determined that their thickness measures are within 1%.
Another challenge is that the parameters of a magnetic resonance sequence are interrelated. For example, if the goal is to produce a T 2 * map of a healing graft, a small voxel (ie, a 3-dimensional pixel) size would be ideal. A smaller voxel size will enable the researcher to look at discrete locations within the ligament while minimizing partial volume artifacts, but it will also result in a smaller signal:noise ratio. The optimization of certain variables generally requires the sacrifice of other variables. Therefore, it is important to work with experts in magnetic resonance physics and radiology when selecting a sequence to obtain a quantitative imaging outcome variable to address the clinical research question. The need to include a magnetic resonance expert on the study team is not unlike the need to include a biostatistician when designing a study, no matter how simple the experimental design may be. MRI is advantageous for looking at the soft tissue structures of the joint; however, it can be expensive and time-consuming. Working with a team that has the expertise in imaging will help reduce time and costs. Finally, it is important to make sure all imaging measures are repeatable, within and across examiners, and that the measure has predictive validity.
The value of MRI in musculoskeletal research is immense and ever changing. MRI can be utilized to track changes in structure, composition, and functionimportant parameters related to biomechanics. Due to cost and expense, some imaging methods may not be readily used in the clinic to direct routine clinical care. However, these methods could still serve as a valuable outcome measure for clinical research that would indirectly affect the future of clinical care. For example, if MRI was used to longitudinally assess cartilage health in a study comparing 2 surgical techniques to treat an ACL injury and if one of those surgical methods showed less joint arthrosis, it would be clear which technique should be used in clinical practice. Another example would be the use of MRI to predict the strength of a healing ligament, which could provide insight into optimal rehabilitation strategies and the appropriateness of timing for athletes to return to sport. These simple examples demonstrate the value of imaging as a biomechanical outcome measure for musculoskeletal research. It is an exciting time in orthopaedic research, as we now have the tools to directly and noninvasively assess the biomechanical integrity of healing tissues.
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